Modeled Survival Gains of Patients with Cystic Fibrosis...

Modeled Survival Gains of Patients with Cystic Fibrosis (CF) Aged ≥12 Years Homozygous for the F508dEL Mutation Treated with the CF Transmembrane Conductance Regulator Modulator (CFTRM) Tezacaftor/Ivacaftor (TEZ/IVA)

Lopez, A, Suthoff, E, Chandler, C, Liou, T, Konstan, M, Pelligra, C, Ward, A, Rubin, J, McGarry, L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.1392
Date:
May, 2018
File:
PDF, 77 KB
english, 2018
Conversion to is in progress
Conversion to is failed